LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 117 | -33.5% | 0.00% | – |
| Q2 2023 | $0 | – | 176 | +252.0% | 0.00% | – |
| Q1 2023 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 50 | -80.2% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 252 | -39.0% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 413 | -0.5% | 0.00% | – |
| Q1 2022 | $4,000 | +100.0% | 415 | +91.2% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 217 | +1.9% | 0.00% | – |
| Q3 2021 | $2,000 | -33.3% | 213 | -15.1% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 251 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 251 | +248.6% | 0.00% | – |
| Q4 2020 | $3,000 | +200.0% | 72 | +89.5% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 38 | -32.1% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 56 | -71.6% | 0.00% | – |
| Q1 2020 | $1,000 | – | 197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 407,192 | $6,714,000 | 1.63% |
| Investors Financial Group, LLC | 115,260 | $1,901,000 | 1.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,169 | $15,437,000 | 0.45% |
| NEA Management Company, LLC | 526,663 | $8,685,000 | 0.35% |
| Logos Global Management LP | 50,000 | $825,000 | 0.16% |
| Wealth Advisors of Iowa, LLC | 11,760 | $194,000 | 0.15% |
| Blackstone Inc. | 468,145 | $7,720,000 | 0.03% |
| Jefferies Group LLC | 120,651 | $1,990,000 | 0.02% |
| Texas Yale Capital Corp. | 15,000 | $247,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,043 | $199,000 | 0.00% |